ScanBalt Digital Forum 2020

4 September 2020, Germany.
ScanBalt invites European cluster organisations to join the formulation of a joint declaration on the necessary next steps to create the Common European Health Data Space. Clusters are invited to draw on the experience of their cluster members such as universities, hospitals, research institutions, pharmaceutical and med-tech companies and start-ups. The Joint Declaration will be presented to the German Council Presidency for its Council conclusions and further recommendations.

The current COVID 19 crises raises awareness of the need of data and best practise exchange and underlines the need for action. To learn and be better prepared for the future, it is important to gather the innovative digital solutions from the different areas of care, for example:

  • Research (exchange of patient-related data in cross-border research projects, for example in infectiology or pharmacology)
  • Patient care and nursing (cross-border coordination of capacities)
  • Use of innovative digital apps (e.g. early warning system for new waves of infection or for monitoring social distancing measures)
  • Suggestions for a fast track approval of digital solutions

Our aim is to collect and analyse the input on the above-mentioned topics and to formulate the joint declaration to be discussed at the ScanBalt Forum on the 4th of September 2020.

Due to potential travel restrictions, the ScanBalt Forum 2020 will be held for the first time as a purely digital conference. The Forum will focus on the examples that are provided by European cluster organizations and will bound these examples together with the help of panel discussions to a Joint Declaration. The Forum, as the Joint Declaration, has four Tracks:

  • The cross-country collaboration on healthcare between European member states. The COVID-19 crisis has shown that we urgently need new possibilities for health data exchange across borders.
  • Digital solution for the next generation of health research. University hospitals, research institutions, pharmaceutical /medtech companies and public health authorities rely on the possibility to exchange data for improving their business and the treatment of the European public.
  • Digital solutions for a resilient population protection. COVID-19 has underlined the need for a consolidated and harmonized European digital infrastructure (tracing/early pandemic warning systems etc.). The future of the European idea of open borders and freedom of movement relies also on those technical solutions.
  • Digital solutions for a protective elderly care and health care systems. In this chapter we will examine how digital solution could improve healthcare and elderly care systems regarding COVID-19 treatment and beyond.

For further information and to register, please visit:
https://scanbalt.org/scanbaltforum2020/

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...